Abstract
Objective: We aimed to elucidate, through systematic review and meta-analysis, how exposure to selenium can influence the activation of the PI3K/Akt/GLUT-4 signaling pathway in animal models of diabetes. Methods: Search was performed in the PubMed/Medline, Cochrane Library, LILACS, Web of Science, and Scopus databases, without a time limit, with a focus on studies conducted in animal models of diabetes. Results: 13 articles were included in this review. The findings show that selenium supplementation resulted in increased expression of the GLUT-4 protein, as well as improved fasting glucose, fasting insulin, and HOMA-IR in animal model, disregarding studies conducted on humans that show a diabetogenic effect of this mineral in many studies conducted. Similarly, this meta-analysis shows controversies results regarding modulation of the PI3K/Akt/GLUT-4 pathway and glucose metabolism in different animal models. Final considerations: The relationship between selenium and insulin signaling is complex and dependent on dose, compound, and tissue, is important to interpret these results carefully.
References
ALHARITHY M, ALAFIF N. Association of Selenium Intake and Selenium Concentrations with Risk of Type 2 Diabetes in Adults: A Narrative Review. Metabolites, 2023; 13: 767.
ABDULMALEK AS, BALBAA M. Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers. PLoS One, 2019; 14: e0220779.
AL-QURAISHY S, et al. Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats. International Journal of Nanomedicine, 2015; 10: 6741–6756.
BARAKAT GM, et al. Effects of Selenium and Exendin-4 on Glucagon-Like Peptide-1 Receptor, IRS-1, and Raf-1 in the Liver of Diabetic Rats. Biochemical Genetits, 2012; 50: 922–935.
BARAKAT G, et al. Effects of exendin-4 and selenium on the expression of GLP-1R, IRS-1, and preproinsulin in the pancreas of diabetic rats. Journal of Physiology Biochemistry, 2017; 73: 387-394.
CAI X, et al. Dosage-effect of selenium supplementation on blood glucose and oxidative stress in type 2 diabetes mellitus and normal mice. Journal of Trace Elements in Medicine and Biology, 2024; 3: 127410.
DUBEY P, et al. Role of Minerals and Trace Elements in Diabetes and Insulin Resistance. Nutrients, 2020; 12: 1864.
FARROKHIAN A, et al. Selenium Supplementation Affects Insulin Resistance and Serum hs-CRP in Patients with Type 2 Diabetes and Coronary Heart Disease. Hormone and Metabolic Research, 2016; 48: 263-268.
HASSAN RM, et al. Mitigating effect of single or combined administration of nanoparticles of zinc oxide, chromium oxide, and selenium on genotoxicity and metabolic insult in fructose/streptozotocin diabetic rat model. Environmental Science and Pollution Research, 2021; 28: 48517-48534.
HE J, et al. Nano-selenium modulates glucose metabolism and reduces insulin resistance through activation of the PI3K/Akt pathway in diabetic mice. Journal of Trace Element in Medicine and Biology, 2019; 81: 127130.
HEI YJ, et al. Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes. Molecular and Cellular Biochemistry, 1998; 178: 367-375.
HWANG D, et al. Selenium acts as an insulin-like molecule for the down-regulation of diabetic symptoms via endoplasmic reticulum stress and insulin signalling proteins in diabetes-induced non-obese diabetic mice. Journal of Biosciences, 2007; 32: 723–735.
JABŁOŃSKA E, RESZKA E. Selenium and Epigenetics in Cancer: Focus on DNA Methylation. Advances in Cancer Research, 2017; 136 :193-234.
KIM SS, et al. Exercise training and selenium or a combined treatment ameliorates aberrant expression of glucose and lactate metabolic proteins in skeletal muscle in a rodent model of diabetes. Nutrition Research and Practice, 2011; 5: 205-213.
LABUNSKYY VM, et al. Selenoproteins: molecular pathways and physiological roles. Physiological Reviews, 2014; 94: 739-777.
LE TKC, et al. Insulin signaling and its application. Frontiers in Endocrinology, 2023; 14: 1226655.
LIU T, et al. Dual role of selenium in oxidative stress and insulin signaling: dose-dependent effects in metabolic disorders. Free Radical Biology and Medicine, 2023; 207: 146–157.
MATTMILLER SA, et al. Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis. Journal of Nutritional Science, 2013; 2: e28.
MCNEILL JH, et al. Insulinlike effects of sodium selenate in streptozocin-induced diabetic rats. Diabetes 1991; 40: 1675-1678.
MISU H, et al. Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PLoS One, 2012; 7: e34952.
MISU H, et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metabolism, 2010; 12: 483-495.
MITA, Y., et al. Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models. Nature Communications, 2017; 8: 1658.
MURANO K, et al. Role of supplementary selenium on the induction of insulin resistance and oxidative stress in NSY mice fed a high fat diet. Biolpgical & Pharmaceutical Bulletin, 2018; 41: 92-98.
NORTON L, et al. Insulin: The master regulator of glucose metabolism. Metabolism, 2022; 129: 155142.
SAITO Y. Selenoprotein P as an in vivo redox regulator: disorders related to its deficiency and excess. Journal of Clinical Biochemistry and Nutrition, 2020; 66: 1-7.
SHI Y, et al. Trace Elements, PPARs, and Metabolic Syndrome. International Journal of Molecular Sciences, 2020; 21: 2612.
SPECKMANN B, et al. Selenium increases hepatic DNA methylation and modulates one-carbon metabolism in the liver of mice. The Journal of Nutritional Biochemistry, 2017; 48: 112-119.
STAHEL P, et al. Supranutritional selenium intake from enriched milk casein impairs hepatic insulin sensitivity via attenuated IRS/PI3K/AKT signaling and decreased PGC-1α expression in male Sprague–Dawley rats. The Journal of Nutritional Biochemistry, 2017; 41: 142–150.
STAPLETON SR, et al. Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. Biochimica et Biophysica Acta, 1997; 1355: 259-269.
STRÓŻYK A, et al. Effectiveness and safety of selenium supplementation for type 2 diabetes mellitus in adults: a systematic review of randomised controlled trials. Journal of Human Nutrition and Dietetics, 2019; 32: 635-645.
WANG Q, et al. Increased Expression of PHGDH Under High-Selenium Stress In Vivo. Biological Trace Element Research, 2024; 202: 5145-5156.
WANG C, et al. Long-Term Supranutritional Supplementation with Selenate Decreases Hyperglycemia and Promotes Fatty Liver Degeneration by Inducing Hyperinsulinemia in Diabetic db/db Mice. PLoS One, 2014; 9: e101315.
WANG Z, et al. Selenium supplementation improves hepatic insulin sensitivity via NRF2 and PPARγ activation in diabetic models. Redox Biology, 2022; 224:102311.
XU, TJ, et al. The effect of insulin in combination with selenium on blood glucose and GLUT4 expression in the cardiac muscle of streptozotocin-induced diabetic rats. Fundamental & Clinical Pharmacology, 2010; 24: 199-204.
YANG J, et al. Selenium deficiency-induced thioredoxin suppression and thioredoxin knock down disbalanced insulin responsiveness in chicken cardiomyocytes through PI3K/Akt pathway inhibition. Cellular Signalling, 2017; 38: 192-200.
ZHENG D, et al. Comparative profiling of serum, urine, and feces bile acids in humans, rats, and mice. Communications Biology, 2024; 7: 641.
ZHOU X, et al. Selenium-enriched exopolysaccharides improve skeletal muscle glucose uptake of diabetic KKAy mice via AMPK pathway. Journal of Physiology and Biochemistry, 2014a; 70: 547–554.
ZHOU J, et al. Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway. Toxicology and Applied Pharmacology, 2015; 289:409-418.
ZHOU J, et al. Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway. Toxicol Appl Pharmacol, 2015; 289: 409-418.
ZHOU X, et al. Selenium enriched exopolysaccharides produced by Enterobacter cloacae Z0206 alleviate adipose inflammation in diabetic KKAy mice through the AMPK/SirT1 pathway. Molecular Medicine Reports, 2014b; 9: 683-688.
